시장보고서
상품코드
1566203

투석 시장 규모, 점유율, 성장 분석, 유형별, 제품·서비스별, 최종사용자별, 지역별 - 산업 예측(2024-2031년)

Dialysis Market Size, Share, Growth Analysis, By Type (Hemodialysis, Peritoneal Dialysis), By Products and Services (Equipment, Consumables), By End User (In-center Dialysis, Home Dialysis), By Region - Industry Forecast 2024-2031

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 157 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 투석 시장 규모는 2022년에 1,108억 달러에 달하며, 2023년 1,158억 2,000만 달러에서 2031년까지는 1,624억 5,000만 달러로 성장하며, 예측 기간(2024-2031년)의 CAGR은 4.32%로 성장할 전망입니다.

투석 시장은 만성 신장질환의 유병률이 크게 증가함에 따라 신장 클리닉에서 치료를 받으려는 환자가 증가함에 따라 강력한 성장세를 보이고 있습니다. 특히 미국 메디케어 및 메디케이드 서비스 센터(CMS)를 중심으로 한 민간 및 정부 기관의 지불 정책 강화가 이러한 추세를 지원하고 있습니다. 예를 들어 2019년 CMS는 약 7,000개의 말기 신장질환(ESRD) 프로바이더에 혈액투석 비용을 충당하기 위해 약 103억 달러의 메디케어 상환금을 배정했습니다. 이러한 재정적 지원은 향후 수년간 시장 확대에 박차를 가할 것으로 예상됩니다. 미국 국립보건원(NIH)에 따르면 COVID 환자의 약 5%가 신장 대체요법을 필요로 하며, 많은 중증 환자가 급성 신장 손상으로 고통받고 있습니다. 이러한 긴급한 수요를 충족시키기 위해 병원들은 신장 치료 장비를 도입하고 있으며, 이는 시장의 성장 궤도에 더욱 박차를 가하고 있습니다. 그 결과, 미국 시장 상황은 지속적인 성장이 예상되며 향후 예측 기간 중 안정적인 CAGR을 달성할 것으로 예상됩니다. 이는 신장 관련 질환에 대한 의료 수요와 치료 상황의 진화를 반영하고 있습니다.

목차

서론

  • 조사의 목적
  • 정의
  • 시장 범위

조사 방법

  • 정보 조달
  • 2차·1차 정보원
  • 시장 규모 예측
  • 시장의 전제조건과 제한

개요

  • 시장 개요 전망
  • 공급 수요 동향 분석
  • 부문별 기회 분석

시장 역학과 전망

  • 시장 역학
    • 촉진요인
    • 기회
    • 억제요인
    • 과제
  • Porter의 산업 분석

주요 시장 인사이트

  • 주요 성공 요인
  • 경쟁의 정도
  • 주요 투자 기회
  • 시장의 에코시스템
  • 특허 분석
  • 기술 분석
  • 규제 상황

투석 시장 : 유형별

  • 시장 개요
  • 혈액투석
    • 기존 혈액투석
    • 단기 투석
    • 야간 혈액투석
  • 복막 투석
    • 지속 휴대용 복막 투석(CAPD) 투석
    • 자동 복막 투석(APD)

투석 시장 : 제품·서비스별

  • 시장 개요
  • 서비스
  • 장비
    • 투석 장비
    • 수치료 시스템
    • 기타
  • 소모품
    • 투석 장비
    • 카테터
    • 기타
  • 투석 약제

투석 시장 : 최종사용자별

  • 시장 개요
  • 센터내 투석
  • 재택 투석

투석 시장 규모 : 지역별

  • 시장 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 이탈리아
    • 기타 유럽 지역
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카 지역
  • 중동 및 아프리카(MEA)
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카 지역

경쟁 구도

  • 상위 5사의 비교
  • 주요 기업의 시장 포지셔닝(2023년)
  • 주요 시장 기업이 채택한 전략
  • 시장에서의 최근 활동
  • 주요 기업의 시장 점유율(2023년)

주요 기업 개요

  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton Dickinson and Company
  • DaVita Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • JMS Co. Ltd.
  • Medtronic plc
  • Nikkiso Co. Ltd.
  • NIPRO Corporation
  • Satellite Healthcare Inc.
  • Toray Industries Inc.
  • Diaverum Deutschland GmbH
  • NxStage Medical, Inc.
  • Rockwell Medical Technologies, Inc.
  • AllMed Medical GmbH
  • Fresenius Kabi AG
  • Quanta Dialysis Technologies Ltd.
  • Outset Medical, Inc.
  • Medica S.p.A
KSA 24.10.15

Global Dialysis Market size was valued at USD 110.80 billion in 2022 and is poised to grow from USD 115.82 billion in 2023 to USD 162.45 billion by 2031, growing at a CAGR of 4.32% during the forecast period (2024-2031).

The dialysis market is experiencing robust growth due to a significant rise in chronic kidney disease prevalence, leading to more patients seeking treatment at renal clinics. Enhanced payment policies from commercial and government entities, particularly the Centers for Medicare & Medicaid Services (CMS), support this trend; for instance, in 2019, CMS allocated roughly US$ 10.3 billion in Medicare reimbursements to around 7,000 end-stage renal disease (ESRD) providers to cover hemodialysis costs. This financial backing is expected to fuel market expansion in the coming years. Additionally, the recent COVID-19 pandemic has exacerbated the demand for renal equipment, as many critically ill patients suffer from acute kidney injury, with about 5% of COVID cases requiring renal replacement therapy according to the National Institutes of Health (NIH). Hospitals are increasingly adopting renal therapy equipment to meet this urgent need, further driving the market's growth trajectory. As a result, the US dialysis market is positioned for sustained growth, projected to achieve a consistent compound annual growth rate (CAGR) in the upcoming forecast period, reflecting both the pressing healthcare demands and the evolving treatment landscape for kidney-related disorders.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Dialysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Dialysis Market Segmental Analysis

Global Dialysis Market is segmented by Type, Products and Services, End User, and Region. Based on Type, the market is segmented into Hemodialysis (Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis), Peritoneal Dialysis (Continuous Ambulatory Peritoneal Dialysis (CAPD), Automated Peritoneal Dialysis (APD)). Based on Products and Services, the market is segmented into Services, Equipment (Dialysis Machines, Water Treatment Systems, Others), Consumables (Dialyzers, Catheters, Others), Dialysis Drugs. Based on End User, the market is segmented into In-center Dialysis, Home Dialysis. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Dialysis Market

The escalating prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) is a significant market driver for the global dialysis market. As the burden of ESRD increases, necessitating long-term renal therapies or transplants, healthcare systems face immense financial pressures, thereby escalating the demand for efficient dialysis services. With approximately 15% of the U.S. population affected by CKD, the urgency for accessible renal care is heightened. Additionally, the expansion of nephrology specialists and renal care facilities in developed nations, coupled with investments aimed at establishing dialysis centers in emerging markets like India and China, underscores a robust growth trajectory. This demand for affordable yet effective renal treatments is projected to fuel substantial market revenue generation, making it a pivotal factor in the global dialysis landscape.

Restraints in the Global Dialysis Market

The global dialysis market faces significant restraint due to the growing preference for kidney transplantation as a treatment for end-stage renal disease (ESRD) and stage III chronic kidney disease (CKD). Patients often opt for transplantation over dialysis, attracted by the potential for better long-term outcomes and improved quality of life. Favorable reimbursement policies make kidney transplantation a more financially viable option, further driving this shift. Additionally, the rising costs associated with renal therapy, exacerbated by the coronavirus pandemic-especially in countries like India-may deter patients from opting for dialysis, ultimately hindering market growth and adoption of dialysis treatments.

Market Trends of the Global Dialysis Market

The Global Dialysis market is witnessing a significant trend of transitioning from traditional clinic-based care to homecare settings, driven by patient preferences, especially in developed economies. This shift is complemented by government initiatives, particularly in the United States, aimed at promoting cost-effective home treatment options for end-stage renal disease (ESRD). The emergence of advanced renal care technologies, including innovative dialysis machines and efficient dialyzers, is further propelling market growth, with key players like B.Braun and Fresenius Kabi leading the charge in product development. The focus on enhancing accessibility to homecare is expected to attract a growing number of patients seeking convenient and personalized treatment options, heralding a transformative phase in the dialysis landscape.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Types
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Ecosystem of the Market
  • Patent Analysis
  • Technology Analysis
  • Regulatory Landscape

Dialysis Market, By Type

  • Market Overview
  • Hemodialysis
    • Conventional Hemodialysis
    • Short Daily Hemodialysis
    • Nocturnal Hemodialysis
  • Peritoneal Dialysis
    • Continuous Ambulatory Peritoneal Dialysis (CAPD)
    • Automated Peritoneal Dialysis (APD)

Dialysis Market, By Products and Services

  • Market Overview
  • Services
  • Equipment
    • Dialysis Machines
    • Water Treatment Systems
    • Others
  • Consumables
    • Dialyzers
    • Catheters
    • Others
  • Dialysis Drugs

Dialysis Market, By End User

  • Market Overview
  • In-center Dialysis
  • Home Dialysis

Dialysis Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Asahi Kasei Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter International Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton Dickinson and Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DaVita Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fresenius Medical Care AG & Co. KGaA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • JMS Co. Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nikkiso Co. Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NIPRO Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Satellite Healthcare Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Toray Industries Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Diaverum Deutschland GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NxStage Medical, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rockwell Medical Technologies, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AllMed Medical GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fresenius Kabi AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Quanta Dialysis Technologies Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Outset Medical, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medica S.p.A
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제